Early Dutasteride Monotherapy in Patients With Elevated Serum Prostate-Specific Antigen Levels Following Robot-Assisted Radical Prostatectomy
Chin-Heng Lu(Tungs' Taichung MetroHarbor Hospital), Min‐Che Tung(National Chung Hsing University), Li‐Hua Huang(Zhujiang Hospital), Yen‐Chuan Ou(Tungs' Taichung MetroHarbor Hospital), Wei‐Chun Weng(Mackay Junior College of Medicine, Nursing and Management), Yu‐Kang Chang(Tungs' Taichung MetroHarbor Hospital), Chao‐Yu Hsu(National Chung Hsing University), Hung-Lin Chen(Biogen (United States))
Cited by 2
Related Papers
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Oncology|2020|502
Outcome of Surgery for Clinical Unilateral T3a Prostate Cancer: A Single-Institution Experience
|European Urology|2006|176
Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
|European Urology|2010|154
Pathological results and rates of treatment failure in high‐risk prostate cancer patients after radical prostatectomy
|British Journal of Urology|2010|141